Taiwan Liposome

$4.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.47%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell TLC and other stocks, options, and ETFs commission-free!

About TLC

Taiwan Liposome Co., Ltd. engages in the authorized cooperative development of special medicine as well as new formulation and prescription drugs. The firm offers pain management, ophthalmology, and oncology related drugs based on lipid drug delivery system. It also provides royalties and biotechnology services. The company was founded by Chi Lung Hung on November 10, 1997 and is headquartered in Taipei, Taiwan. The listed name for TLC is Taiwan Liposome Company, Ltd. American Depository Shares.

CEO
Keelung Hong
Employees
Headquarters
Taipei, Taipei City
Founded
1997
Market Cap
181.37M
Price-Earnings Ratio
Dividend Yield
Average Volume
24.06K
High Today
$4.39
Low Today
$4.31
Open Price
$4.39
Volume
8.11K
52 Week High
$12.65
52 Week Low
$2.48

Collections

TLC Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 9, Pre-Market

You May Also Like